Modulation of T-regulatory cells by small molecules: potential therapy for GvHD
Allogeneic haematopoietic stem cell transplantation (alloHSCT) is often curative for patients suffering from blood cancers. Nonetheless, significant morbidity and mortality are still prevalent. One major complication is graft versus host disease (GvHD) which occurs in 30-70% of patients. In this dis...
第一著者: | Leuschner, U |
---|---|
その他の著者: | Roberts, D |
フォーマット: | 学位論文 |
言語: | English |
出版事項: |
2021
|
類似資料
-
Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation
著者:: Mauro Di Ianni, 等
出版事項: (2024-01-01) -
The Role of Bacteria and Pattern Recognition Receptors in GvHD
著者:: E. Holler, 等
出版事項: (2010-01-01) -
Fibroblastic reticular cells mitigate acute GvHD via MHCII-dependent maintenance of regulatory T cells
著者:: Haroon Shaikh, 等
出版事項: (2022-11-01) -
Bone marrow GvHD after allogeneic hematopoietic stem cell transplantation
著者:: Martin eSzyska, 等
出版事項: (2016-03-01) -
Immunometabolic Therapeutic Targets of Graft-versus-Host Disease (GvHD)
著者:: Kudakwashe Mhandire, 等
出版事項: (2021-10-01)